Cargando…
Eosinopenia <100/μL as a marker of active COVID-19: An observational prospective study
OBJECTIVES: To analyse the diagnostic performance of eosinopenia, alone or combined with polymorphonuclear neutrophils (PMN) and/or lymphocytes, as a marker of active COVID-19 in patients hospitalized for suspicion of SARS-CoV-2 infection. METHODS: A prospective observational study including patient...
Autores principales: | Outh, Roderau, Boutin, Caroline, Gueudet, Philippe, Suzuki, Marcelino, Saada, Matthieu, Aumaître, Hugues |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792500/ https://www.ncbi.nlm.nih.gov/pubmed/33468435 http://dx.doi.org/10.1016/j.jmii.2020.12.005 |
Ejemplares similares
-
Relevance of eosinopenia as an early sepsis marker
por: Moura, EB, et al.
Publicado: (2011) -
Is eosinopenia a reliable marker of sepsis?
por: Smithson, Alex, et al.
Publicado: (2009) -
Eosinopenia as a marker of sepsis and mortality in critically ill patients
por: Savitskiy, A, et al.
Publicado: (2015) -
Eosinopenia as an early diagnostic marker of COVID-19 at the time of the epidemic
por: Xia, Zhengyuan
Publicado: (2020) -
Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units
por: Abidi, Khalid, et al.
Publicado: (2008)